Inulin-type fructans and 2’fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial

• Published in: The American journal of clinical nutrition Vol. 118; no. 5; pp. 938 - 955
• Main Authors: Jackson, Peter PJ, Wijeyesekera, Anisha, Williams, Claire M., Theis, Stephan, van Harsselaar, Jessica, Rastall, Robert A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.11.2023; American Society for Clinical Nutrition, Inc; American Society for Nutrition
• Subjects: 2’fucosyllactose; Adult; Anxiety; Bacteria; Bifidobacterium; Composition; Digestive system; Double-Blind Method; Emotions; Flow cytometry; Fluorescence in situ hybridization; Fructans; Fructans - pharmacology; Fructooligosaccharides; Gastrointestinal tract; Gene sequencing; gut-brain axis; Humans; In Situ Hybridization, Fluorescence; Intestinal microflora; Inulin - pharmacology; Maltodextrin; Mental depression; Microbiota; Microorganisms; Mood; mood state; oligofructose; Oligosaccharides - pharmacology; Oligosaccharides - therapeutic use; Original; Parameters; Placebos; Prebiotics; rRNA 16S; mood state; 2’fucosyllactose; D; BDI; PHQ-9; FLOW; ANCOVA; GAD-7; FDR; PANAS-SF; OF; FID; PBS; 2’FL; Bifidobacterium; ASV; CI; rRNA; OPLS-DA; HMO; oligofructose; SCFA; PCA; STAI; PA; NMR; RD; NA; CAR; QMP; FISH; GABA; HPA; prebiotics; ITF; PCR; PSQI; gut-brain axis; MGLM
• ISSN: 0002-9165; 1938-3207; 1938-3207
• DOI: 10.1016/j.ajcnut.2023.08.016

There is increasing interest in the bidirectional relationship existing between the gut and brain and the effects of both oligofructose and 2’fucosyllactose to alter microbial composition and mood state. Yet, much remains unknown about the ability of oligofructose and 2’fucosyllactose to improve mood state via targeted manipulation of the gut microbiota. We aimed to compare the effects of oligofructose and 2’fucosyllactose alone and in combination against maltodextrin (comparator) on microbial composition and mood state in a working population. We conducted a 5-wk, 4-arm, parallel, double-blind, randomized, placebo-controlled trial in 92 healthy adults with mild-to-moderate levels of anxiety and depression. Subjects were randomized to oligofructose 8 g/d (plus 2 g/d maltodextrin); maltodextrin 10 g/d; oligofructose 8 g/d plus 2’fucosyllactose (2 g/d) or 2’fucosyllactose 2 g/d (plus 8 g/d maltodextrin). Changes in microbial load (fluorescence in situ hybridization-flow cytometry) and composition (16S ribosomal RNA sequencing) were the primary outcomes. Secondary outcomes included gastrointestinal sensations, bowel habits, and mood state parameters. There were significant increases in several bacterial taxa including Bifidobacterium, Bacteroides, Roseburia, and Faecalibacterium prausnitzii in both the oligofructose and oligofructose/2’fucosyllactose interventions (all P ≤ 0.05). Changes in bacterial taxa were highly heterogenous upon 2’fuscoyllactose supplementation. Significant improvements in Beck Depression Inventory, State Trait Anxiety Inventory Y1 and Y2, and Positive and Negative Affect Schedule scores and cortisol awakening response were detected across oligofructose, 2’fucosyllactose, and oligofructose/2’fucosyllactose combination interventions (all P ≤ 0.05). Both sole oligofructose and oligofructose/2’fuscosyllactose combination interventions outperformed both sole 2’fucosyllactose and maltodextrin in improvements in several mood state parameters (all P ≤ 0.05). The results of this study indicate that oligofructose and combination of oligofructose/2’fucosyllactose can beneficially alter microbial composition along with improving mood state parameters. Future work is needed to understand key microbial differences separating individual responses to 2’fucosyllactose supplementation. This trial was registered at clinicaltrials.gov as NCT05212545.